Clinical Trial Update: A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ABC294640 (Opaganib) alone and in combination with hydroxychloroquine sulfate in advanced cholangiocarcinoma; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Hydroxychloroquine sulfate (Hydroxychloroquine sulfate)
• Opaganib (opaganib)

Snippet

Sponsor: RedHill Biopharma Limited | Conditions: Cholangiocarcinoma, Cholangiocarcinoma Non-resectable | Phase 2 | Status: COMPLETED